Cartilgin® For Osteoarthritis


Each capsule contains:

  • Sodium chondroitin sulphate : 250 mg
  • D-glucosamine HCl : 250 mg
  • Ascorbic acid : 35 mg


Cartilgin® capsule, through its triple component of chondroitin sulphate, glucosamine hydrochloride, and ascorbic acid, is a new and innovative therapy for many pathological conditions that affect the joints to :

  1. Stop the degeneration and improve the regeneration of the cartilage and the joints.
  2. Reduce the pain and inflammation associated with these conditions.
  3. Restore the articular functions through improving the joint mobility and increasing angles of joint’s flexion .

Chondroitin sulphate increases the formation of new cartilage matrix by stimulating chondrocytes metabolism and synthesis of collagen and proteoglycans, which are the main components of the cartilge of the joints. It stimulates also the production of highly polymerized hyaluronic acid by the synovial cells improving viscosity and returning synovial fluid level to normal.

Glucosamine is an amino sugar which is a main part of the glycosaminoglycans, that stimulates the production of cartilage components and allows rebuilding of damaged cartilage thus restoring articular function.

Ascorbic acid (vitamin C) stops the free radicals mediated articular and cartilaginous damages through its antioxidant effect thus preventing more damage to the joint.


  1. Treatment of osteoarthritis, either degenerative or traumatic, and any other painful and degenerative joint conditions.
  2. As an adjuvant therapy during the treatment of rheumatoid disorders affecting joints to stop their further degeneration and promote their healing.
  3. Prevention or postponing the occurrence of osteoarthritis occuring commonly in the elderly, postmenopausal women and the athletes .

Adverse reactions

Generally, Cartilgin® is safe and well tolerated. However, mild forms of gastrointestinal disturbances in the form of nausea, vomiting, abdominal pain, diarrhea or constipation may rarely occur.

Contraindications and precautions

Cartilgin® should not be used in patients with known hypersensitivity to any of its components.

The use of Cartilgin® by patients with bleeding disorders or those who are on an anticoagulant therapy should be under strict medical supervision because chondroitin sulphate has an anticoagulant effect that may increase the susceptiblity to bleeding.

Pregnancy and lactation

It is not recommended to use Cartilgin® during pregnancy and lactation, as there are no studies performed to measure the safety of glucosamine and chondroitin sulphate during pregnancy and lactation.

Dosage and administration

One to two capsules to be swallowed as a whole with or after meals three times/ day or as directed by the physician.

How supplied

strips of 10 capsules in packs of 2 strips

Keep all medicaments out of reach of children

Product of: AMOUN PHARMACEUTICAL CO. El-Obour City, Cairo, Egypt.